Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (167)	3/13/1999 4:36:00 AM
From: Steve Patterson	Read Replies (1) \| Respond to of 10293

Warning: mildly offensive post follows. (re: MCHM) Wow! I guess you can get financing for any silly idea, so long as it sounds like a real pharmaceutical startup. Let's see...MCHM wants to find out if ibuprofen works better when you rub it on your knee. Maybe they can cross-license their "miracle absorbing agent" to ZONA and they can claim Vasomax acts even faster if you rub it on your wang. But wait -- someone already did that study, and it doesn't. Rats! We investors are in the wrong business -- the real money appears to be in starting silly companies, and it doesn't appear to be very difficult. Let's see...since studies show that eating cruciferous vegetables decreases the risk of colon cancer, we'll patent and submit an NDA for a broccoli suppository. "AnuChem's new, patented formulation fights cancer and is tapered for easy insertion." It's worth millions! Steve